2-溴-4-氟苯甲醛置于四氢吡咯,盐酸,Titanium(Iv) Tetraethanolate,1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物,Sodium Methylate,Sodium Carbonate,三乙胺,Copper(L) Chloride,锌体系中,用 四氢呋喃,甲醇,乙二醇二甲醚,乙醚,乙醇,二氯甲烷 作为反应溶剂,化学反应 82.33H,反应生成 (R)-2-氨基-7-[4-氟-2-(6-甲氧基吡啶-2-基)苯基]-4-甲基-7,8-二氢-6H-吡啶并[4,3-D]嘧啶-5-酮
参考文献:Design,Structure-activity Relationship,And In Vivo Characterization Of The Development Candidate Nvp-Hsp990
标题:Design,Structure-activity Relationship,And In Vivo Characterization Of The Development Candidate Nvp-Hsp990
摘要:Utilizing Structure-Based Drug Design,A Novel Dihydropyridopyrimidinone Series Which Exhibited Potent Hsp90 Inhibition,Good Pharmacokinetics Upon Oral Administration,And An Excellent Pharmacokinetic/pharmacodynamic Relationship In Vivo Was Developed From A Commercial Hit. The Exploration Of This Series Led To The Selection Of Nvp-Hsp990 As A Development Candidate.
DOI:10.1021/jm501107Q